Clinical Trial Update: Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting

View source ↗

Summary

A completed real-world trial update evaluating atorvastatin effectiveness and safety in cardiology patients, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Hypercholesterolemia
• Hypertension

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Coronary Artery Disease, Hypercholesterolemia, Hypertension | Status: COMPLETED | Results posted: 2019-11-04